Evidence map›Paper›PMID 23097045›Full record

ArticleJournal of cell science2012

Src binds cortactin through an SH2 domain cystine-mediated linkage.

Jason V Evans, Amanda G Ammer, John E Jett, Chris A Bolcato, Jason C Breaux, Karen H Martin, Mark V Culp, Peter M Gannett, Scott A Weed

Abstract read
In one paragraph

Article in Journal of cell science, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. NEDD9 targetsScience translational medicine · 2018
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Adducin is required for desmosomal cohesion in keratinocytes.The Journal of biological chemistry · 2014
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jason V EvansDepartment of Neurobiology and Anatomy, Program in Cancer Cell Biology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV 26506, USA.
Amanda G Ammer
John E Jett
Chris A Bolcato
Jason C Breaux
Karen H Martin
Mark V Culp
Peter M Gannett
Scott A Weed
West Virginia University · US

Funding

THE ROLE OF HEF1 PROTEIN IN INVASION OF METASTATIC BREAST CANCERP20RR016440 · NCRR · WEST VIRGINIA UNIVERSITY · PI IVANOV, ALEXEY · 2001 to 2010
$22.8M
West Virginia Flow Cytometry Core FacilityP30GM103488 · NIGMS · WEST VIRGINIA UNIVERSITY · PI GIBSON, LAURA F. · 2012 to 2016
$4.8M
Cortactin in Cell Motility and InvasionR01DE014578 · NIDCR · WEST VIRGINIA UNIVERSITY · PI WEED, SCOTT A · 2003 to 2007
$1.4M
COBRE FOR SIGNAL TRANSDUCTION AND CANCER PHASE IIIP30RR032138 · NCRR · WEST VIRGINIA UNIVERSITY · PI GIBSON, LAURA F. · 2011 to 2011
$1.1M
Role of Cortactin in Tyrosine Kinase SignalingK22DE014364 · NIDCR · WEST VIRGINIA UNIVERSITY · PI WEED, SCOTT A · 2002 to 2005
$540k
NCRR NIH HHS P20 RR016440NCRR NIH HHS P30 RR032138NCRR NIH HHS RR16440NIDCR NIH HHS DE014364NIDCR NIH HHS DE014578NIDCR NIH HHS K22 DE014364NIDCR NIH HHS R01 DE014578NIGMS NIH HHS P30 GM103488NIGMS NIH HHS P30 RR032138/GM103488
6 · The paper itself

Abstract

Tyrosine-kinase-based signal transduction mediated by modular protein domains is critical for cellular function. The Src homology (SH)2 domain is an important conductor of intracellular signaling that binds to phosphorylated tyrosines on acceptor proteins, producing molecular complexes responsible for signal relay. Cortactin is a cytoskeletal protein and tyrosine kinase substrate that regulates actin-based motility through interactions with SH2-domain-containing proteins. The Src kinase SH2 domain mediates cortactin binding and tyrosine phosphorylation, but how Src interacts with cortactin is unknown. Here we demonstrate that Src binds cortactin through cystine bonding between Src C185 in the SH2 domain within the phosphotyrosine binding pocket and cortactin C112/246 in the cortactin repeats domain, independent of tyrosine phosphorylation. Interaction studies show that the presence of reducing agents ablates Src-cortactin binding, eliminates cortactin phosphorylation by Src, and prevents Src SH2 domain binding to cortactin. Tandem MS/MS sequencing demonstrates cystine bond formation between Src C185 and cortactin C112/246. Mutational studies indicate that an intact cystine binding interface is required for Src-mediated cortactin phosphorylation, cell migration, and pre-invadopodia formation. Our results identify a novel phosphotyrosine-independent binding mode between the Src SH2 domain and cortactin. Besides Src, one quarter of all SH2 domains contain cysteines at or near the analogous Src C185 position. This provides a potential alternative mechanism to tyrosine phosphorylation for cysteine-containing SH2 domains to bind cognate ligands that may be widespread in propagating signals regulating diverse cellular functions.

Indexed as

Amino Acid SequenceCell LineCortactinCystineHumansModels, MolecularMolecular Sequence DataPhosphorylationProtein BindingSignal Transductionsrc-Family Kinasessrc Homology DomainsCortactinCystinesrc-Family Kinases

Identifiers

PMID23097045
PMCPMC3585525
OpenAlexW2116723580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.